Literature DB >> 28719587

Outcomes research: Integrating PROs into the clinic - overall survival benefit or not, it's worth the trouble.

Elisa Sperti1, Massimo Di Maio2.   

Abstract

Year:  2017        PMID： 28719587     DOI： 10.1038/nrclinonc.2017.109

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.

Authors:  Ethan Basch; Allison M Deal; Amylou C Dueck; Howard I Scher; Mark G Kris; Clifford Hudis; Deborah Schrag
Journal:  JAMA       Date:  2017-07-11       Impact factor: 56.272

2.  Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.

Authors:  Massimo Di Maio; Ciro Gallo; Natasha B Leighl; Maria Carmela Piccirillo; Gennaro Daniele; Francesco Nuzzo; Cesare Gridelli; Vittorio Gebbia; Fortunato Ciardiello; Sabino De Placido; Anna Ceribelli; Adolfo G Favaretto; Andrea de Matteis; Ronald Feld; Charles Butts; Jane Bryce; Simona Signoriello; Alessandro Morabito; Gaetano Rocco; Francesco Perrone
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

3.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

4.  Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.

Authors:  Massimo Di Maio; Simona Signoriello; Alessandro Morabito; Antonio Rossi; Paolo Maione; Francovito Piantedosi; Domenico Bilancia; Silvio Cigolari; Santi Barbera; Vittorio Gebbia; Bruno Daniele; Sergio Federico Robbiati; Alfonso Illiano; Anna Ceribelli; Francesco Carrozza; Adolfo Favaretto; Elena Piazza; Maria Carmela Piccirillo; Gennaro Daniele; Pasqualina Giordano; Raffaele Costanzo; Claudia Sandomenico; Gaetano Rocco; Ciro Gallo; Francesco Perrone; Cesare Gridelli
Journal:  Lung Cancer       Date:  2012-01-31       Impact factor: 5.705

Review 5.  Patient-reported outcomes in the evaluation of toxicity of anticancer treatments.

Authors:  Massimo Di Maio; Ethan Basch; Jane Bryce; Francesco Perrone
Journal:  Nat Rev Clin Oncol       Date:  2016-01-20       Impact factor: 66.675

6.  The missing voice of patients in drug-safety reporting.

Authors:  Ethan Basch
Journal:  N Engl J Med       Date:  2010-03-11       Impact factor: 91.245

Review 7.  Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Betty R Ferrell; Jennifer S Temel; Sarah Temin; Erin R Alesi; Tracy A Balboni; Ethan M Basch; Janice I Firn; Judith A Paice; Jeffrey M Peppercorn; Tanyanika Phillips; Ellen L Stovall; Camilla Zimmermann; Thomas J Smith
Journal:  J Clin Oncol       Date:  2016-10-28       Impact factor: 44.544

Review 8.  Patient-reported outcomes and the evolution of adverse event reporting in oncology.

Authors:  Andy Trotti; A Dimitrios Colevas; Ann Setser; Ethan Basch
Journal:  J Clin Oncol       Date:  2007-11-10       Impact factor: 44.544

9.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Authors:  Ethan Basch; Allison M Deal; Mark G Kris; Howard I Scher; Clifford A Hudis; Paul Sabbatini; Lauren Rogak; Antonia V Bennett; Amylou C Dueck; Thomas M Atkinson; Joanne F Chou; Dorothy Dulko; Laura Sit; Allison Barz; Paul Novotny; Michael Fruscione; Jeff A Sloan; Deborah Schrag
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544
  9 in total
  7 in total

1.  The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.

Authors:  Chiara Baratelli; Carmela Giovanna Cleopatra Turco; Gaetano Lacidogna; Elisa Sperti; Francesca Vignani; Donatella Marino; Clizia Zichi; Emmanuele De Luca; Marco Audisio; Daniela Ballaminut; Annalisa Bellezza; Paola Chiotto; Giovanna Ciriolo; Rossella Comite; Fulvia Codegone; Santina Florio; Luisa Fusco; Laura Polimeno; Donatella Pozzi; Eliana Zilio; Sabrina Terzolo; Massimo Di Maio
Journal:  Support Care Cancer       Date:  2019-04-04       Impact factor: 3.603

2.  COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice.

Authors:  Laura Marandino; Andrea Necchi; Massimo Aglietta; Massimo Di Maio
Journal:  JCO Oncol Pract       Date:  2020-05-01

3.  Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.

Authors:  W Y Cheung; P Kavan; A Dolley
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

4.  A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes.

Authors:  S Ahmed; L Barbera; S J Bartlett; D G Bebb; M Brundage; S Bryan; W Y Cheung; N Coburn; T Crump; L Cuthbertson; D Howell; A F Klassen; S Leduc; M Li; N E Mayo; G McKinnon; R Olson; J Pink; J W Robinson; M J Santana; R Sawatzky; R S Moxam; S Sinclair; F Servidio-Italiano; W Temple
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

5.  An analysis of missing items in real-world electronic patient reported outcomes data: implications for clinical care.

Authors:  Heather A Rosett; Susan C Locke; Steven P Wolf; Kris W Herring; Gregory P Samsa; Jesse D Troy; Thomas W LeBlanc
Journal:  Support Care Cancer       Date:  2020-02-10       Impact factor: 3.603

Review 6.  Patient-reported outcomes in cancer care - hearing the patient voice at greater volume.

Authors:  Thomas W LeBlanc; Amy P Abernethy
Journal:  Nat Rev Clin Oncol       Date:  2017-10-04       Impact factor: 66.675

7.  Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Authors:  Francesca Poggio; Marco Bruzzone; Marcello Ceppi; Benedetta Conte; Samuel Martel; Christian Maurer; Marco Tagliamento; Giulia Viglietti; Lucia Del Mastro; Evandro de Azambuja; Matteo Lambertini
Journal:  ESMO Open       Date:  2018-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.